Tag Archives: John Newman
Canaccord Genuity Sticks to Their Buy Rating for Agios Pharma (AGIO)
In a report released today, John Newman from Canaccord Genuity maintained a Buy rating on Agios Pharma (AGIO – Research Report), with a price target of $70.00. The company’s shares closed last Friday at $35.87. According to TipRanks.com, Newman is
Canaccord Genuity Keeps a Buy Rating on Sesen Bio (SESN)
In a report released today, John Newman from Canaccord Genuity maintained a Buy rating on Sesen Bio (SESN – Research Report), with a price target of $5.00. The company’s shares closed last Tuesday at $1.29. According to TipRanks.com, Newman is
Analysts’ Top Healthcare Picks: Atara Biotherapeutics (ATRA), X4 Pharmaceuticals (XFOR)
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Atara Biotherapeutics (ATRA – Research Report) and X4 Pharmaceuticals (XFOR – Research Report) with bullish sentiments. Atara Biotherapeutics (ATRA) Canaccord Genuity analyst
Analysts Have Conflicting Sentiments on These Healthcare Companies: Selecta Biosciences (NASDAQ: SELB), Insulet (NASDAQ: PODD) and Irhythm Technologies (NASDAQ: IRTC)
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Selecta Biosciences (SELB – Research Report), Insulet (PODD – Research Report) and Irhythm Technologies (IRTC – Research Report). Selecta Biosciences (SELB) Canaccord Genuity
Analysts Offer Insights on Healthcare Companies: Oncolytics Biotech (NASDAQ: ONCY) and Greenbrook Tms (Other OTC: GBOKF)
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Oncolytics Biotech (ONCY – Research Report) and Greenbrook Tms (GBOKF – Research Report) with bullish sentiments. Oncolytics Biotech (ONCY) Canaccord Genuity analyst
Analysts Are Bullish on Top Healthcare Stocks: Kaleido Biosciences (KLDO), Irhythm Technologies (IRTC)
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Kaleido Biosciences (KLDO – Research Report) and Irhythm Technologies (IRTC – Research Report) with bullish sentiments. Kaleido Biosciences (KLDO) Canaccord Genuity analyst
